Further, we discuss the potential of SDCs as attractive targets for different therapeutic strategies, given the pleiotropic roles of SDCs in breast cancer pathogenesis via regulating nuclear hormone receptor signaling pathways, microRNAs, and exosome biosynthesis. Here, NR0B1 is linked to breast carcinoma.